Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes

Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes

Introduction: Evidence suggests a survival benefit from resuming angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) post acute kidney injury (AKI) compared to nonuse; however, the optimal timing and its impact on outcomes are unclear. The risks of earlier resumpti...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia-Jin Chen, Cheng-Chia Lee, Chieh-Li Yen, Pei-Chun Fan, Ming-Jen Chan, Tsung-Yu Tsai, Yung-Chang Chen, Chih-Wei Yang, Chih-Hsiang Chang
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Kidney International Reports
Subjects:
ACEI
acute kidney disease
acute kidney injury
ARB
RAAs inhibitor
resumption
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924019120
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items